BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2695754)

  • 1. Analysis of the National Toxicology Program data on in vitro genetic toxicity tests using multivariate statistical methods.
    Benigni R
    Mutagenesis; 1989 Nov; 4(6):412-9. PubMed ID: 2695754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationships between in vitro mutagenicity assays.
    Benigni R
    Mutagenesis; 1992 Sep; 7(5):335-41. PubMed ID: 1470028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What indication is common to different genotoxicity data bases?
    Benigni R; Giuliani A
    Mutat Res; 1991 Oct; 253(2):115-21. PubMed ID: 1922137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of four in vitro genetic toxicity tests for predicting rodent carcinogenicity: confirmation of earlier results with 41 additional chemicals.
    Zeiger E; Haseman JK; Shelby MD; Margolin BH; Tennant RW
    Environ Mol Mutagen; 1990; 16 Suppl 18():1-14. PubMed ID: 2091921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of chemical carcinogenicity in rodents from in vitro genetic toxicity assays.
    Tennant RW; Margolin BH; Shelby MD; Zeiger E; Haseman JK; Spalding J; Caspary W; Resnick M; Stasiewicz S; Anderson B
    Science; 1987 May; 236(4804):933-41. PubMed ID: 3554512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A bootstrap analysis of four in vitro short-term test performances.
    Benigni R
    Mutat Res; 1989 Apr; 216(2):127-35. PubMed ID: 2927414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of the genotoxic activities observed in vitro for 35 of 70 NTP noncarcinogens.
    Ashby J; Purchase IF
    Environ Mutagen; 1985; 7(5):747-58. PubMed ID: 3899632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity.
    Kirkland D; Aardema M; Henderson L; Müller L
    Mutat Res; 2005 Jul; 584(1-2):1-256. PubMed ID: 15979392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens II. Further analysis of mammalian cell results, relative predictivity and tumour profiles.
    Kirkland D; Aardema M; Müller L; Makoto H
    Mutat Res; 2006 Sep; 608(1):29-42. PubMed ID: 16769241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mouse bone marrow micronucleus assay: relationships with in vitro mutagenicity and rodent carcinogenicity.
    Benigni R
    J Toxicol Environ Health; 1995 Jul; 45(3):337-47. PubMed ID: 7609006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic toxicology: can we design predictive in vivo assays?
    Clive D
    Mutat Res; 1988; 205(1-4):313-30. PubMed ID: 3285193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rational approach to the quantification of genotoxicity.
    Benigni R
    Environ Mol Mutagen; 1992; 19(1):83-9. PubMed ID: 1732108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An approach to identifying specialized batteries of bioassays for specific classes of chemicals: class analysis using mutagenicity and carcinogenicity relationships and phylogenetic concordance and discordance patterns. 1. Composition and analysis of the overall data base. A report of phase II of the U.S. Environmental Protection Agency Gene-Tox Program.
    Ray VA; Kier LD; Kannan KL; Haas RT; Auletta AE; Wassom JS; Nesnow S; Waters MD
    Mutat Res; 1987 May; 185(3):197-241. PubMed ID: 3574331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of rodent carcinogens and noncarcinogens using genetic toxicity tests: premises, promises, and performance.
    Zeiger E
    Regul Toxicol Pharmacol; 1998 Oct; 28(2):85-95. PubMed ID: 9927558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knowledge-based battery design of short-term tests based on dose information.
    Buzzi R; Würgler FE
    Mutat Res; 1990 Oct; 234(5):269-88. PubMed ID: 2215543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting rodent carcinogenicity using potency measures of the in vitro sister chromatid exchange and chromosome aberration assays.
    Schildcrout JS; Margolin BH; Zeiger E
    Environ Mol Mutagen; 1999; 33(1):59-64. PubMed ID: 10037324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ability of short-term tests to predict carcinogenicity can be summarized in a single index.
    Benigni R
    J Toxicol Environ Health; 1991 Sep; 34(1):27-37. PubMed ID: 1890692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The genetic toxicity database of the National Toxicology Program: evaluation of the relationships between genetic toxicity and carcinogenicity.
    Tennant RW
    Environ Health Perspect; 1991 Dec; 96():47-51. PubMed ID: 1820276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Data selection and treatment of chemicals tested for genotoxicity and carcinogenicity.
    Loprieno N; Boncristiani G; Loprieno G; Tesoro M
    Environ Health Perspect; 1991 Dec; 96():121-6. PubMed ID: 1820253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The results of assays in Drosophila as indicators of exposure to carcinogens.
    Vogel EW; Graf U; Frei HJ; Nivard MM
    IARC Sci Publ; 1999; (146):427-70. PubMed ID: 10353398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.